Historical record - last NADAC publication: 5/17/2023

Product Information

QC INFANT PAIN-FEVER 160 MG/5 is a generic product labeled by Chain Drug Marketing Association, priced at $0.0567 per ML under NDC 63868067760. Its NADAC has been published 7 times since May 17, 2023.

QC INFANT PAIN-FEVER 160 MG/5

ACETAMINOPHEN
$0.0567per ML
OTC

Strength

160 mg/5mL

NDC

63868067760

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

5/17/2023

Active Ingredients

ACETAMINOPHEN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

2/1/2021

Price Statistics

The NADAC for QC INFANT PAIN-FEVER 160 MG/5 has been published 7 times since May 17, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0567 per ML
All-time high$0.0567 (Jun 28, 2023)
All-time low$0.0567 (May 17, 2023)
Median price$0.0567
Average price$0.0567
Largest weekly change0.0% (May 24, 2023)
Weeks tracked7
Tracking sinceMay 17, 2023

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

N/A

All

0.0%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 62%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of QC INFANT PAIN-FEVER 160 MG/5?

The current National Average Drug Acquisition Cost (NADAC) for QC INFANT PAIN-FEVER 160 MG/5, manufactured by Chain Drug Marketing Association, is $0.0567 per ML (NDC 63868067760), effective Jun 28, 2023.

How has the price of QC INFANT PAIN-FEVER 160 MG/5 changed over time?

Over the history we have for it, the NADAC for QC INFANT PAIN-FEVER 160 MG/5 has held within roughly two percent of its current level. It has been tracked across 7 weekly CMS publications since May 17, 2023.

What are the highest and lowest recorded NADAC prices for QC INFANT PAIN-FEVER 160 MG/5?

Since May 17, 2023, the NADAC for QC INFANT PAIN-FEVER 160 MG/5 has ranged from a low of $0.0567 (May 17, 2023) to a high of $0.0567 (Jun 28, 2023), with a median of $0.0567 per ML.

Are there cheaper alternatives to QC INFANT PAIN-FEVER 160 MG/5?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CHILD PAIN-FEVER 160 MG/5 ML, is $0.0214 per ML — about 62% below QC INFANT PAIN-FEVER 160 MG/5.

Who manufactures QC INFANT PAIN-FEVER 160 MG/5?

QC INFANT PAIN-FEVER 160 MG/5 (NDC 63868067760) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.